Table 1 Demographic, clinical and outcome characteristics according to ventilator types.

From: 1-year survival rate of SARS-CoV-2 infected patients with acute respiratory distress syndrome based on ventilator types: a multi-center study

Variables

Total patients (n = 1078)

ICU ventilator (n = 781)

Transport ventilator (n = 297)

P-value

Age

 Mean ± SD

52.96 ± 14.46

53.02 ± 14.2

52.82 ± 15.06

0.836

Gender (%)

 Male (%)

737 (68.4)

521 (66.7)

216 (72.7)

0.058

 Female (%)

341 (31.6)

260 (33.3)

81 (27.3)

 

APACHE II

 Mean ± SD

15.40 ± 2.28

15.44 ± 2.25

15.28 ± 2.33

0.321

Re-admission (%)

 Yes

29 (2.7)

21 (2.7)

8 (2.7)

0.997

Lesions distribution (%)

 Bilateral + Multifocal

931 (86.4)

678 (86.8)

253 (85.2)

0.487

 Others

147 (13.6)

103 (13.2)

44 (14.8)

 

Lesions type (%)

 GGO

414 (38.4)

298 (38.2)

116 (39.1)

0.786

 GGO + crazy paving

133 (12.3)

104 (13.3)

29 (9.8)

0.113

 Consolidation

42 (3.9)

29 (3.7)

13 (4.4)

0.615

 GGO + Consolidation

489 (45.4)

350 (44.8)

139 (46.8)

0.558

Other findings (%)

 None

695 (64.5)

511 (65.4)

184 (62)

0.897

 Liner opacity

174 (16.1)

124 (15.9)

50 (16.8)

0.703

 Reversed Halo sign

49 (4.5)

39 (5)

10 (3.4)

0.252

 Pleural effusion

55 (5.1)

44 (5.6)

11 (3.7)

0.198

 Interalesional traction bronchiectasis

61 (5.7)

36 (4.6)

25 (8.4)

0.016*

 Lymphadenopathy

44 (4.1)

27 (3.5)

17 (5.7)

0.093

Underlying diseases (%)

 None

1041 (96.6)

760 (97.3)

281 (94.6)

0.189

 Pulmonary

7 (0.6)

4 (0.5)

3 (1)

 

 Cardiac

28 (2.6)

16 (2)

12 (4)

 

 Kidney

2 (0.2)

1 (1)

1 (0.3)

 

Presence diffuse opacity (%)

 Yes

181 (16.8)

122 (15.6)

58 (19.5)

0.124

 No

897 (83.2)

659 (84.4)

239 (80.5)

 

Number of involved lobe (%)

No lobe involved

897 (83.2)

658 (84.3)

239 (80.5)

0.142

 1

6 (0.6)

4 (0.5)

2 (0.7)

0.550

 2

49 (4.5)

39 (5)

10 (3.4)

0.001*

 3

50 (4.6)

31 (4)

19 (6.4)

0.001*

 4

43 (4)

30 (3.8)

13 (4.4)

0.001*

 5

33 (3.1)

19 (2.4)

14 (4.7)

0.001*

Total opacity score

 Mean ± SD

6.14 ± 5.55

5.95 ± 5.31

6.60 ± 6.13

0.089

MV duration

 Mean ± SD

250 ± 109.1

254.53 ± 109.7

238.02 ± 106.55

0.026*

Outcomes (%)

 Live

956 (88.7)

708 (90.7)

248 (83.5)

0.001*

 Death

122 (11.3)

73 (9.3)

49 (16.5)

 

 In-hospital mortality

12/122 (9.8)

7 (0.9)

5 (1.7)

0.004*

 Out-of-hospital

110/122 (91.2)

66 (8.5)

44 (14.8)

 
  1. GGO: Ground-glass opacities, APACHE: Acute Physiology and Chronic Health Evaluation (APACHE) II, * P < 0.05 was statistically significant.